Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe.
What is Senseonics Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate SENS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate SENS's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SENS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SENS's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SENS's dividend in 3 years as they are not forecast to pay a notable one for the US market.
What is the CEO of Senseonics Holdings's salary, the management and board of directors tenure and is there insider trading?
0.8yrs
Average management tenure
CEO
TimGoodnow(57yo)
4yrs
Tenure
US$2,171,443
Compensation
Dr. Timothy T. Goodnow, also known as Tim, Ph.D., has been the Chief Executive Officer, President and Director of Senseonics Holdings, Inc. since December 2015. Dr. Goodnow served as the Chief Executive Of ...
CEO Compensation Analysis
Compensation vs Market: Tim's total compensation ($USD2.17M) is above average for companies of similar size in the US market ($USD1.13M).
Compensation vs Earnings: Tim's compensation has increased whilst the company is unprofitable.
Management Age and Tenure
0.8yrs
Average Tenure
48yo
Average Age
Experienced Management: SENS's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Age and Tenure
4.0yrs
Average Tenure
60yo
Average Age
Experienced Board: SENS's board of directors are considered experienced (4 years average tenure).
Insider Trading
Insider Buying: SENS insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
BuyUS$97,35011 Sep 19
Timothy Goodnow
Entity
Individual
Role
Chief Executive Officer
President
Shares
88,500
Max Price
US$1.10
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.6%.
Management Team
Jon Isaacson (48yo)
Tenure: 0.08yrs
Tim Goodnow (57yo)
President
Tenure: 4yrs
Compensation: US$2.17m
Fran Kaufman (68yo)
Chief Medical Officer & Director
Tenure: 0.08yrs
Mukul Jain (46yo)
Chief Operating Officer
Tenure: 2.9yrs
Compensation: US$1.38m
Nick Tressler (46yo)
Chief Financial Officer
Tenure: 0.08yrs
Board Members
Doug Roeder (48yo)
Non-Management Director
Tenure: 4yrs
Compensation: US$158.73k
Ed Fiorentino (60yo)
Non-Management Director
Tenure: 4yrs
Compensation: US$155.63k
Stephen DeFalco (57yo)
Chairman
Tenure: 4yrs
Compensation: US$172.25k
Tim Goodnow (57yo)
President
Tenure: 4yrs
Compensation: US$2.17m
Fran Kaufman (68yo)
Chief Medical Officer & Director
Tenure: 0.08yrs
Michael Helmus (65yo)
Member of Scientific Advisory Board
Tenure: 0yrs
Doug Prince (65yo)
Non-Management Director
Tenure: 4yrs
Compensation: US$164.88k
Peter Klein (41yo)
Non-Management Director
Tenure: 4yrs
Compensation: US$155.63k
James Anderson (78yo)
Member of Scientific Advisory Board
Tenure: 0yrs
Michael Pishko
Member of Scientific Advisory Board
Tenure: 0yrs
Company Information
Senseonics Holdings, Inc.'s company bio, employee growth, exchange listings and data sources
Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include ...
Company Analysis and Financial Data Status
All financial data provided by Standard & Poor's Capital IQ.
Data
Last Updated (UTC time)
Company Analysis
2019/12/07 00:49
End of Day Share Price
2019/12/06 00:00
Earnings
2019/09/30
Annual Earnings
2018/12/31
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.